Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Morphine: a Novel Intervention to Maximize the Benefits of Exercise Training in Adults With Chronic Lung Disease and Persistent Breathlessness?

NCT03824834 is registered in ClinicalTrials.gov with Dennis Jensen, Ph.D. as lead sponsor.

NCT NCT03824834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03824834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Morphine: a Novel Intervention to Maximize the Benefits of Exercise Training in Adults With Chronic Lung Disease and Persistent Breathlessness?
Lead sponsor
Dennis Jensen, Ph.D.
Phase
Phase 2
Overall status
Unknown status
Start date
August 6, 2019
Completion date
November 30, 2020
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease, interstitial lung disease